[HTML][HTML] Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update
I Trulson, S Holdenrieder - Tumor Biology, 2023 - content.iospress.com
BACKGROUND: Therapeutic possibilities for non-small cell lung cancer (NSCLC) have
considerably increased during recent decades. OBJECTIVE: To summarize the prognostic …
considerably increased during recent decades. OBJECTIVE: To summarize the prognostic …
[HTML][HTML] Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies
M van den Heuvel, S Holdenrieder… - Tumor …, 2024 - content.iospress.com
BACKGROUND: The value of serum tumor markers (STMs) in the current therapeutic
landscape of lung cancer is unclear. OBJECTIVE: This scoping review gathered evidence of …
landscape of lung cancer is unclear. OBJECTIVE: This scoping review gathered evidence of …
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study
K Morimoto, T Yamada, T Takeda, S Shiotsu, K Date… - Targeted Oncology, 2023 - Springer
Background Osimertinib monotherapy is a common treatment for epidermal growth factor
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC); however, standard treatment …
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC); however, standard treatment …
Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma
LX Feng, J Wang, Z Yu, SA Song, WX Zhai… - Clinical and …, 2019 - Springer
Objective To study the clinical significance of serum epidermal growth factor receptor
(EGFR) gene mutation and serum tumor markers in the prediction of tyrosine kinase inhibitor …
(EGFR) gene mutation and serum tumor markers in the prediction of tyrosine kinase inhibitor …
Integrative omics analysis reveals soluble cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer
TF Hsiao, CL Wang, YC Wu, HP Feng, YC Chiu… - Clinical Cancer …, 2020 - AACR
Purpose: EGFR tyrosine kinase inhibitors (EGFR-TKI) benefit patients with advanced lung
adenocarcinoma (ADC) harboring activating EGFR mutations. We aimed to identify …
adenocarcinoma (ADC) harboring activating EGFR mutations. We aimed to identify …
TTF-1 expression predicts the merit of additional antiangiogenic treatment in non-squamous non-small cell lung cancer
A Takeuchi, T Oguri, Y Yamashita, K Sone… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: To investigate whether TTF-1 expression predicts a beneficial response of
non-squamous non-small-cell lung cancer (NS-NSCLC) patients to bevacizumab. Patients …
non-squamous non-small-cell lung cancer (NS-NSCLC) patients to bevacizumab. Patients …
Serum SP 70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer
J Liu, W Zhang, M Gu, Y Ji, L Yang, X Cheng… - Cancer …, 2018 - Wiley Online Library
SP 70 is a novel tumor biomarker in patients with nonsmall cell lung cancer (NSCLC).
However, its role as a marker for predicting the response to chemotherapy for patients with …
However, its role as a marker for predicting the response to chemotherapy for patients with …
[HTML][HTML] The diagnostic significance of 64-slice spiral CT combined with serological CA19-9, Bcl-2, CYFRA21-1 detection in thoracic esophageal carcinoma
J Hao, W Liu, C Zhao, T Xia - Translational Cancer Research, 2021 - ncbi.nlm.nih.gov
Background To analyze the clinical value of multi-slice spiral computed tomography (MSCT)
combined with carbohydrate antigen 19-9 (CA19-9), B-cell leukemia/lymphoma-2 protein …
combined with carbohydrate antigen 19-9 (CA19-9), B-cell leukemia/lymphoma-2 protein …
Prognostic role for CYFRA 21-1 in patients with advanced-stage NSCLC treated with bevacizumab plus chemotherapy
M Svaton, J Blazek, G Krakorova, M Pesek… - Anticancer …, 2021 - ar.iiarjournals.org
Aim: To investigate potential associations between selected oncomarkers [carcinoembryonic
antigen (CEA), C-terminus of cytokeratin 19 (CYFRA 21-1, CYFRA), and squamous cell …
antigen (CEA), C-terminus of cytokeratin 19 (CYFRA 21-1, CYFRA), and squamous cell …
[Retracted] Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
C Wu, B Chen, M Wang, Y Tang - … ‐Based Complementary and …, 2022 - Wiley Online Library
The changes in lifestyle and bad living habits have a significant impact on the health of
people, resulting in an increasing prevalence of lung cancer. The most prevalent kind of …
people, resulting in an increasing prevalence of lung cancer. The most prevalent kind of …